Sign In
Buy RDY
$13.02
-0.0100 (-0.0767%)
At Close: Jun 03, 2026
The Zacks Analyst Blog Highlights JD.com, Sigma Lithium, Dr. Reddys Laboratories, MakeMyTrip and Coupang
03:46pm, Thursday, 22'nd Dec 2022 Zacks Investment Research
JD.com, Sigma Lithium, Dr. Reddys Laboratories, MakeMyTrip and Coupang are part of the Zacks top Analyst Blog.
5 Best Emerging Markets Stocks to Buy for 2023
02:43pm, Wednesday, 21'st Dec 2022 Zacks Investment Research
Here are five emerging market stocks, JD, SGML, RDY, MMYT and CPNG that are expected to gain enormously in 2023, capitalizing on their growth prospects.
5 Best Emerging Markets Stocks to Buy for 2023
11:17am, Wednesday, 21'st Dec 2022
Here are five emerging market stocks, JD, SGML, RDY, MMYT and CPNG that are expected to gain enormously in 2023, capitalizing on their growth prospects.
Doctor Reddy's (RDY) Gains As Market Dips: What You Should Know
11:15pm, Monday, 19'th Dec 2022 Zacks Investment Research
Doctor Reddy's (RDY) closed at $52.85 in the latest trading session, marking a +0.3% move from the prior day.
Doctor Reddy's (RDY) Gains But Lags Market: What You Should Know
11:15pm, Tuesday, 13'th Dec 2022 Zacks Investment Research
Doctor Reddy's (RDY) closed at $54.62 in the latest trading session, marking a +0.57% move from the prior day.
Zacks Industry Outlook Highlights Dr. Reddy's, Amphastar Pharmaceuticals and Sol-Gel Technologies
11:16am, Thursday, 08'th Dec 2022 Zacks Investment Research
Dr. Reddy's, Amphastar Pharmaceuticals and Sol-Gel Technologies have been highlighted in this Industry Outlook article.
Doctor Reddy's (RDY) Gains As Market Dips: What You Should Know
11:15pm, Wednesday, 07'th Dec 2022 Zacks Investment Research
In the latest trading session, Doctor Reddy's (RDY) closed at $53.25, marking a +0.02% move from the previous day.
3 Generic Drug Stocks to Watch Amid Inflation Pressures
03:52pm, Wednesday, 07'th Dec 2022 Zacks Investment Research
The impact of inflationary headwinds and pricing pressure on the Zacks Medical - Generic Drugs industry persists. New product launches provide some respite to AMPH, RDY and SLGL.
3 Generic Drug Stocks to Watch Amid Inflation Pressures
12:02pm, Wednesday, 07'th Dec 2022
The impact of inflationary headwinds and pricing pressure on the Zacks Medical - Generic Drugs industry persists. New product launches provide some respite to AMPH, RDY and SLGL.
New Strong Buy Stocks for November 17th
12:17pm, Thursday, 17'th Nov 2022 Zacks Investment Research
PSX, DCP, RDY, PDFS and CRZBY have been added to the Zacks Rank #1 (Strong Buy) List on November 17, 2022.
New Strong Buy Stocks for November 17th
09:02am, Thursday, 17'th Nov 2022
PSX, DCP, RDY, PDFS and CRZBY have been added to the Zacks Rank #1 (Strong Buy) List on November 17, 2022.
Doctor Reddy's (RDY) is a Top-Ranked Momentum Stock: Should You Buy?
02:50pm, Friday, 11'th Nov 2022 Zacks Investment Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
TEVA Misses on Q3 Earnings, Cuts 2022 Sales View, Stock Down
12:03pm, Friday, 04'th Nov 2022
TEVA reports dismal Q3 results, missing estimates for both earnings and sales. It slightly lowers its sales expectations for 2022 while keeping the adjusted earnings per share guidance intact.
Dr. Reddy's (RDY) Earnings & Revenues Trump Estimates in Q2
03:01pm, Monday, 31'st Oct 2022 Zacks Investment Research
Dr. Reddy's (RDY) earnings and sales beat estimates in second-quarter fiscal 2023.
Dr. Reddy's (RDY) Earnings & Revenues Trump Estimates in Q2
12:03pm, Monday, 31'st Oct 2022
Dr. Reddy's (RDY) earnings and sales beat estimates in second-quarter fiscal 2023.
